/Companies

ApoGen Biotechnologies

Seattle, US · Founded 2014 · Delaware corporation · 4 known investors

Find your way into ApoGen Biotechnologies

Sign up to see every warm intro you have to ApoGen Biotechnologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ApoGen Biotechnologies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

TL
Thong LeNamed on SEC filing
KG
Keno GutierrezNamed on SEC filing
JS
John SantiniNamed on SEC filing
MJ
M. Johnston ErwinNamed on SEC filing
IA
Ian A.W. HowesNamed on SEC filing
JM
Joel MarcusNamed on SEC filing
JS
James SullivanNamed on SEC filing

Board

SGSteve Gillis
Steve GillisBoard directorManaging Director at ARCH Venture Partners
AXAsish Xavier
Asish XavierBoard directorVice President, Venture Investments at JJDC

Investors · 4

Funding

SEC filings, press & company announcements

$7.6M disclosed across 1 of 2 rounds · 2016–2018

▶$7.6MraisedAug 2018 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thong LeExecutive Officer, Director
  • Keno GutierrezDirector
  • Steve GillisDirector
  • John SantiniDirector
  • M. Johnston ErwinDirector
  • Asish XavierDirector
  • Ian A.W. HowesExecutive Officer
  • Joel MarcusDirector
  • James SullivanDirector
Offering amount
$7.6M
Amount sold
$7.6M
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are ApoGen Biotechnologies's investors?
ApoGen Biotechnologies's investors include M Ventures, ARCH Venture Partners, Johnson & Johnson Innovation – JJDC, WRF Capital.
How much funding has ApoGen Biotechnologies raised?
ApoGen Biotechnologies has disclosed $7.6M raised across 1 of its 2 known rounds.
Where is ApoGen Biotechnologies headquartered?
ApoGen Biotechnologies is headquartered in Seattle, US.